Oral Manifestations among Coronavirus Disease 2019 Patients: Evidence from the Thar Desert Region of India
Journal of Public Health and Primary Care · 2023
DOI: 10.4103/jphpc.jphpc_11_23 ↗Astratt
Introduction: The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been known to cause fever, cough, and difficulty in breathing. However, several case studies and case reports have also documented alteration of taste, dryness of mouth, and vesiculobullous lesion, but there is a scarcity of planned epidemiological studies to provide scientific evidence regarding such associations. Thus, this study was conducted to assess oral manifestations in symptomatic coronavirus disease 2019 (COVID-19) patients. Subjects and Methods: A cross-sectional study was conducted in a dedicated COVID facility of Jodhpur. Mild and moderate symptomatic laboratory-confirmed cases of COVID-19 were included in the study. Data collection was done using the WHO Oral Health Self-Assessment Questionnaire for adults. Compiled data were analyzed using Chi-square statistics and odds ratio considering P < 0.05 as statistically significant. Results: Out of 351 participants, 65.5% developed oral manifestations, with ageusia being the most common with 56.4% prevalence. Significant associations of the manifestations were observed with chronic systemic conditions and oral deleterious habits. Conclusion: The study provided epidemiological evidence regarding oral manifestations due to SARS-CoV-2 infection and their associations with chronic conditions and oral deleterious habits. Due to the continued resurgence of COVID-19, it is recommended that oral evaluation and management accompany the routine treatment in infected patients.
EUVIMED